PLATINUM-RESISTANT PRIMARY PERITONEAL CARCINOMA
Clinical trials for PLATINUM-RESISTANT PRIMARY PERITONEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PLATINUM-RESISTANT PRIMARY PERITONEAL CARCINOMA trials appear
Sign up with your email to follow new studies for PLATINUM-RESISTANT PRIMARY PERITONEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo tested to fight tough ovarian cancer
Disease control CompletedThis study tested two ways of giving immunotherapy drugs to women with ovarian cancer that had returned or stopped responding to standard chemotherapy. One hundred participants received the drugs either together or one after the other to see which approach was better at controlli…
Matched conditions: PLATINUM-RESISTANT PRIMARY PERITONEAL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New hope for Tough-to-Treat ovarian cancer
Disease control CompletedThis study tested a new drug called SL-172154, given alongside one of two standard chemotherapy drugs, in people with ovarian cancer that had stopped responding to platinum-based treatments. The main goals were to find a safe dose and see if the combinations showed early signs of…
Matched conditions: PLATINUM-RESISTANT PRIMARY PERITONEAL CARCINOMA
Phase: PHASE1 • Sponsor: Shattuck Labs, Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC